Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Beta Tech BETA stock weaker than competitors In Focus 20260418 LYTS LSI Industries Inc posts 195 percent Q1 2026 EPS beat shares gain 536 percent on positive investor sentiment Is Dorman DORM stock attractive at current levels Q4 2025 Profit Disappoints Why Armstrong AWI Stock Is Popular Extends Gains 20260418 IQ iQIYI Inc American Depositary Shares posts narrower Q4 2025 loss shares tick higher on upbeat investor reaction Is Owlet OWLT stock underpriced in the market Owlet Inc posts 74 EPS beat vs analyst estimates GECCH Great Elm reports quarterly earnings for 8125 notes due 2022 amid market volatility Hoth Therapeutics HOTH Stock Volume Volatility Bearish Momentum 20260418 TKO Group Holdings Inc TKO posts wide Q4 2025 EPS miss shares fall 116 percent on soft investor sentiment Is Five9 FIVN stock undervalued Ticks Higher 20260418 What you need to know before buying Gabelli GGZ Marginal Gain 20260506 LAW CS Disco shares surge 78 as narrowerthanexpected loss exceeds Wall Street expectations Marine MPX Stock Pattern Formation Review Marine Posts 30 EPS Miss Amid Soft Boating Demand Pressures ALPS ALPS Group management outlines targeted healthcare unit growth plans during its latest quarterly earnings call Why Celcuity CELC valuation makes sense when you dig deeper Momentum Fading 20260505 WRBH WR reveals 2061 subordinated debenture strategic priorities in its latest quarterly earnings report What GlobalE Online GLBE does that builds long term value Q4 2025 Earnings Beat Estimates Why Sabre Corporation SABR looks attractive at current levels Selloff Intensifies 20260505 H2O America SPGI Q1 2026 Earnings Align With Guidance Robust Capital Pipeline Supports LongTerm Growth WD Walker and Q4 2025 EPS misses estimates by 132 percent shares drop 082 percent in todays trade KR Kroger shares slide 271 percent as Q1 2026 EPS beat fails to lift investor sentiment OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025